Scinovex
articleTop 1% cited

Corticosteroid Therapy for Critically Ill Patients with Middle East Respiratory Syndrome

American Journal of Respiratory and Critical Care Medicine · 2017 · Vol. 197(6) · pp. 757–767
Yaseen M. ArabiYasser MandourahFahad Al-HameedAnees SindiGhaleb A. AlmekhlafiMohamed A. HusseinJesna JoseRuxandra PintoAwad Al‐OmariAyman KharabaAbdullah AlmotairiKasim Al KhatibBasem AlraddadiSarah ShalhoubAhmed AbdulmomenIsmael QushmaqAhmed MadyOthman SolaimanAbdulsalam M. Al‐AithanRajaa Al‐RaddadiAhmed RagabHanan H. BalkhyAbdulrahman Al HarthyAhmad DeebHanan Al MutairiAbdulaziz Al‐DawoodLaura MersonFrederick G. HaydenRobert Fowler

Abstract

Corticosteroid therapy in patients with MERS was not associated with a difference in mortality after adjustment for time-varying confounders but was associated with delayed MERS coronavirus RNA clearance. These findings highlight the challenges and importance of adjusting for baseline and time-varying confounders when estimating clinical effects of treatments using observational studies.

Sepsis Diagnosis and TreatmentRespiratory Support and MechanismsCOVID-19 Clinical Research StudiesMedicineCorticosteroidOdds ratioHazard ratioConfoundingConfidence intervalInternal medicineMarginal structural modelMechanical ventilationMiddle East respiratory syndrome coronavirus

MeSH terms

Adrenal Cortex HormonesCritical CareFemaleHumansMaleMiddle AgedRetrospective StudiesSaudi ArabiaCohort StudiesCritical IllnessTreatment OutcomeCoronavirus Infections
Citations
1,204
FWCI
113.21
field-weighted impact
References
24
Percentile
100%
vs. same field & year
Citations per year
References
Citation Network

How this paper connects to the literature. Drag to explore, click any node to open that paper.

Corticosteroid Therapy for Critically Ill Patients with Middle East Respiratory Syndrome · Scinovex